Patients with multiple sclerosis at an increased risk for cardiovascular diseasesApril 26, 2022Multiple Sclerosis
Maternal and infant outcomes in pregnant patients with MS treated with natalizumabApril 26, 2022Multiple Sclerosis
Progression independent of relapse activity is a major cause of CDA in early relapsing MSApril 26, 2022Multiple Sclerosis
Multiple sclerosis: B-cell depleting therapies hinder nAb response following SARS-CoV-2 vaccinationApril 26, 2022Multiple Sclerosis
Relapsing MS: Ofatumumab demonstrates superior benefit-risk profile than teriflunomide in RDTN patientsApril 26, 2022Multiple Sclerosis
Adverse childhood experiences associated with increased multiple sclerosis risk in womenApril 26, 2022Multiple Sclerosis
PMS: pNfL could serve as biomarker for disability progression and drug responseApril 26, 2022Multiple Sclerosis
MS: Fingolimod cessation safe if followed by prompt commencement of new therapyApril 26, 2022Multiple Sclerosis
Neighborhood-level data sheds new light on racial and ethnic diversity in MSApril 11, 2022Multiple Sclerosis
